Novo is ramping up manufacturing to satisfy soaring demand from customers in The us, where the drug sells for as much as $1,350 a month. It suggests it's going to carefully watch prescriptions in Germany to ensure access for people with obesity, however it can not not rule out offer delays.Jen Palacios is a researcher and writer at Basic Germany sp